Clariane SE (CLARI.PA)
EUR 1.9
(5.87%)
EUR 1.9
(5.87%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.99 Billion EUR | 13.73% |
| 2022 | 4.43 Billion EUR | 7.27% |
| 2021 | 4.13 Billion EUR | 9.66% |
| 2020 | 3.77 Billion EUR | 4.44% |
| 2019 | 3.61 Billion EUR | 8.27% |
| 2018 | 3.33 Billion EUR | 6.56% |
| 2017 | 3.13 Billion EUR | 5.02% |
| 2016 | 2.98 Billion EUR | 15.86% |
| 2015 | 2.57 Billion EUR | 15.8% |
| 2014 | 2.22 Billion EUR | 63.83% |
| 2013 | 1.35 Billion EUR | 22.38% |
| 2012 | 1.1 Billion EUR | 9.22% |
| 2011 | 1.01 Billion EUR | 9.96% |
| 2010 | 922.86 Million EUR | 8.5% |
| 2009 | 850.58 Million EUR | 8.86% |
| 2008 | 781.32 Million EUR | 28.51% |
| 2007 | 607.97 Million EUR | 18.37% |
| 2006 | 513.64 Million EUR | 81.96% |
| 2005 | 282.28 Million EUR | 75.95% |
| 2004 | 160.43 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 1.31 Billion EUR | -0.3% |
| 2024 Q1 | 1.31 Billion EUR | -48.57% |
| 2023 FY | 5.04 Billion EUR | 13.73% |
| 2023 Q1 | 1.22 Billion EUR | -46.89% |
| 2023 Q4 | 2.56 Billion EUR | 101.64% |
| 2023 Q3 | 1.27 Billion EUR | -48.85% |
| 2023 Q2 | 2.48 Billion EUR | 102.53% |
| 2022 Q3 | 1.14 Billion EUR | -48.71% |
| 2022 Q1 | 1.07 Billion EUR | -51.06% |
| 2022 FY | 4.43 Billion EUR | 7.27% |
| 2022 Q4 | 2.31 Billion EUR | 102.51% |
| 2022 Q2 | 2.22 Billion EUR | 106.23% |
| 2021 Q4 | 2.2 Billion EUR | 105.26% |
| 2021 Q3 | 1.07 Billion EUR | -49.07% |
| 2021 Q2 | 2.1 Billion EUR | 110.07% |
| 2021 Q1 | 1 Billion EUR | -49.78% |
| 2021 FY | 4.13 Billion EUR | 9.66% |
| 2020 Q2 | 1.87 Billion EUR | 104.17% |
| 2020 FY | 3.77 Billion EUR | 4.44% |
| 2020 Q3 | 967.35 Million EUR | -48.45% |
| 2020 Q4 | 1.99 Billion EUR | 106.49% |
| 2020 Q1 | 919.1 Million EUR | -50.19% |
| 2019 FY | 3.61 Billion EUR | 8.27% |
| 2019 Q4 | 1.84 Billion EUR | 100.0% |
| 2019 Q3 | 922.6 Million EUR | -47.77% |
| 2019 Q2 | 1.76 Billion EUR | 99.92% |
| 2019 Q1 | 883.64 Million EUR | 3.71% |
| 2018 Q3 | 852.06 Million EUR | 4.4% |
| 2018 FY | 3.33 Billion EUR | 6.56% |
| 2018 Q1 | 816.18 Million EUR | 2.58% |
| 2018 Q4 | 852.06 Million EUR | 0.0% |
| 2018 Q2 | 816.18 Million EUR | 0.0% |
| 2017 FY | 3.13 Billion EUR | 5.02% |
| 2017 Q4 | 795.63 Million EUR | 0.0% |
| 2017 Q3 | 795.63 Million EUR | 3.35% |
| 2017 Q2 | 769.83 Million EUR | 0.0% |
| 2017 Q1 | 769.83 Million EUR | 1.83% |
| 2016 Q3 | 755.96 Million EUR | 2.89% |
| 2016 Q4 | 755.96 Million EUR | 0.0% |
| 2016 FY | 2.98 Billion EUR | 15.86% |
| 2016 Q1 | 734.73 Million EUR | 12.23% |
| 2016 Q2 | 734.73 Million EUR | 0.0% |
| 2015 Q1 | 631.98 Million EUR | -0.41% |
| 2015 Q4 | 654.66 Million EUR | 0.0% |
| 2015 Q3 | 654.66 Million EUR | 3.59% |
| 2015 Q2 | 631.98 Million EUR | 0.0% |
| 2015 FY | 2.57 Billion EUR | 15.8% |
| 2014 Q3 | 634.59 Million EUR | 33.18% |
| 2014 Q4 | 634.59 Million EUR | 0.0% |
| 2014 FY | 2.22 Billion EUR | 63.83% |
| 2014 Q1 | 476.5 Million EUR | 35.94% |
| 2014 Q2 | 476.5 Million EUR | 0.0% |
| 2013 Q2 | 327.66 Million EUR | 0.0% |
| 2013 FY | 1.35 Billion EUR | 22.38% |
| 2013 Q4 | 350.52 Million EUR | 0.0% |
| 2013 Q3 | 350.52 Million EUR | 6.98% |
| 2013 Q1 | 327.66 Million EUR | 0.0% |
| 2012 FY | 1.1 Billion EUR | 9.22% |
| 2011 FY | 1.01 Billion EUR | 9.96% |
| 2010 FY | 922.86 Million EUR | 8.5% |
| 2009 FY | 850.58 Million EUR | 8.86% |
| 2008 FY | 781.32 Million EUR | 28.51% |
| 2007 FY | 607.97 Million EUR | 18.37% |
| 2006 FY | 513.64 Million EUR | 81.96% |
| 2005 FY | 282.28 Million EUR | 75.95% |
| 2004 FY | 160.43 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Ramsay Générale de Santé SA | 5 Billion EUR | 0.218% |
| LNA Santé SA | 736.08 Million EUR | -578.669% |